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Objectives. The goal of this study was to evaluate clinical and
autonomic variables (heart rate variability and baroreflex sensi-
tivity) related to hemodynamic tolerability of VT in patients with
sustained monomorphic VT and a healed myocardial infarction.
Background. Sustained ventricular tachycardia (VT) with he-
modynamic deterioration is associated with a worse prognosis
than that of well tolerated VT. The causes of hemodynamic
deterioration of VT are incompletely understood.
Methods. Twenty-four consecutive patients with sustained
monomorphic VT and a healed myocardial infarction (mean
age6 SD 666 8 years, left ventricular [LV] ejection fraction 376
11%) were assigned to group 1 if the VT was well tolerated (n 5
11) or to group 2 if faintness or syncope occurred or if systolic
blood pressure was <90 mm Hg with clinical signs of shock (n 5
13).
Results. No difference was found between the two groups in age,
LV function, rate and duration of the VT or heart rate variability.
However, patients in group 2 had a significantly lower baroreflex
sensitivity (3.46 1.1 vs. 7.16 3.7 ms/mm Hg, p5 0.003). Multiple
logistic regression analysis showed that only the value of barore-
flex sensitivity (p5 0.0003)—but not age, LV ejection fraction, VT
cycle length or SD of the RR interval (all p > 0.25)—correlated
with the tolerability of the VT. Finally, LV ejection fraction (p 5
0.0001) and baroreflex sensitivity (p5 0.0003)—but not age, cycle
length of the tachycardia or SD of the RR interval—predicted
cardiac death or unstable VT during follow-up.
Conclusions. These data suggest that an impaired cardiovascu-
lar reflex response may play a key role in the hemodynamic
deterioration of sustained VT and that the evaluation of barore-
flex sensitivity in patients at high risk for sustained VT may
become useful both in risk stratification and in the individualiza-
tion of treatment.
(J Am Coll Cardiol 1997;29:568–75)
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Sustained ventricular tachycardia (VT) with hemodynamic
deterioration is associated with a worse prognosis than that of
well tolerated VT (1). Although the extent of left ventricular
(LV) dysfunction and the VT rate are considered the main
determinants of hemodynamic changes induced by the arrhyth-
mia, symptoms may vary greatly in patients with a similar VT
rate (2). Thus, risk stratification of these patients remains a
problem of considerable clinical relevance.
The goal of this study was to evaluate several clinical and
autonomic variables related to hemodynamic tolerability of VT
in patients with sustained monomorphic VT and a healed
myocardial infarction. We studied heart rate variability and
baroreflex sensitivity, because both markers of cardiac auto-
nomic modulation correlate with mortality after myocardial
infarction (3–6). Specifically, it has been suggested (5–8) that
these markers may identify patients at risk for life-threatening
arrhythmias.
Methods
Study patients. The study enrolled 24 consecutive patients
with a previous myocardial infarction admitted to our coronary
care unit during an episode of sustained monomorphic VT.
Patients with nonsustained or polymorphic VT or ventricular
fibrillation were not enrolled. We also excluded patients with
atrial fibrillation, frequent atrial or ventricular arrhythmias,
insulin-dependent diabetes mellitus, signs or history of central
or peripheral neuropathy and serious concomitant noncardio-
vascular diseases. Patients eligible for the study were prospec-
tively enrolled and were studied on the basis of a predefined
protocol. Of 25 eligible patients, 1 refused to give informed
consent. All 24 enrolled patients were male and had had a
myocardial infarction 6 months to 28 years (mean 13 6 9
years) before enrollment. Their mean age was 666 8 years and
the mean LV ejection fraction was 37 6 11%.
Autonomic assessment. The autonomic study was per-
formed 3 to 7 days after the index arrhythmia. The protocol
was the same used in recent studies (9,10). Patients were
studied while supine at rest in a quiet temperature-controlled
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room, 3 h after a light meal, and they were asked to relax and
to avoid talking and sleeping. The electrocardiographic (ECG)
recording was started after 10 to 15 min of acclimatization.
Heart rate variability was assessed with a Predictor, Corazonix
software. The analog ECG signal was digitized at 500 Hz, the
QRS complex was recognized by cross correlation with a
template chosen by the investigator. Time domain variables
considered in this study were mean RR interval, its SD, mean
squared successive difference (MSSD) and the percent of
cycles differing from the preceding cycle by .50 ms (pNN50).
Power spectral analysis was performed by means of a fast
Fourier transform algorithm with a direct current filter.
Boundaries for the low (LF) and high frequency (HF) regions
were 0.04 to 0.15 Hz and 0.15 to 0.40 Hz, respectively. A very
low frequency peak was generally not revealed by the analysis.
Two recordings of 10 min each were performed, and the
average was utilized for statistical analysis. Because of inade-
quate template recognition, the RR recording of one patient
was excluded from the analysis.
To assess baroreflex sensitivity, blood pressure was mea-
sured noninvasively (Finapres, Ohmeda) and was increased by
15 to 30 mm Hg by intravenous injection of phenylephrine (2
to 4 mg/kg body weight). Baroreflex sensitivity was calculated
as the slope of the linear regression line relating systolic blood
pressure changes to RR interval changes. The average value
derived from three regressions with .20 points and a signifi-
cant correlation was taken as the baroreflex sensitivity.
Patient classification. VT was considered poorly tolerated
if the patient manifested faintness or syncope or presented in the
emergency room with a systolic blood pressure ,90 mm Hg and
clinical signs of shock. Assignment to the group with well toler-
ated VT (group 1) or poorly tolerated VT (group 2) was made
before the autonomic assessment and was subsequently con-
firmed by a consensus agreement of three investigators who
reviewed the clinical data of the presenting arrhythmia without
knowledge of the test results.
Statistical analysis. Data are presented as mean value 6
SD. Normality of the distributions was assessed by the
Kolmogorov-Smirnov test. Differences between the two groups
were assessed by an unpaired t test or by the Wilcoxon
rank-sum test for normally and nonnormally distributed vari-
ables, respectively. Differences in frequency was assessed by
chi-square test. Multiple logistic regression was performed by a
conditional forward stepwise method (SPSS for Windows 6.0).
The model using VT tolerability as a dependent variable
(group 1 vs. 2) included age, LV ejection fraction, cycle length
of the tachycardia, SD of the RR interval and baroreflex
sensitivity as independent variables. The model using cardiac
death or unstable VT as a dependent variable group A vs. B
(see Results, follow-up section) included age, LV ejection
fraction, cycle length of the tachycardia, SD of the RR interval,
baroreflex sensitivity and tolerability of the clinical tachycardia
(categoric variable) as independent variables. No difference in
the variables included in the model was found, in either case,
when a conditional backward stepwise method was used. A p
value , 0.05 was considered significant.
Results
Of the 24 patients enrolled, 11 were assigned to the group
with well tolerated VT (group 1) and 13 to the group with
poorly tolerated VT (group 2). This latter group included
seven patients who had syncope, four patients with clinical
signs of shock (and a systolic blood pressure ,80 mm Hg) and
two patients who had faintness (both had a systolic blood
pressure ,90 mm Hg).
Clinical variables. Table 1 shows the clinical characteris-
tics and the main features of the presenting arrhythmia for
patients of both groups. No significant difference was observed
in mean age, mean LV ejection fraction or frequency of LV
aneurysm (assessed by two-dimensional echocardiography).
Nine patients in group 1 and 11 in group 2 underwent coronary
angiography. No difference was found in the number of vessels
with critical stenoses, and left ventriculography disclosed sim-
ilar diastolic and systolic volumes and ejection fractions. Also,
no difference was found between the two groups in cycle length
of the clinical VT. A nonsignificant trend was observed toward
a greater duration of VT (a reliable estimate was obtained in
22 cases) in group 1 (well tolerated arrhythmia).
Nine patients in group 1 and 12 patients in group 2
underwent an electrophysiologic study for VT induction (the
remaining 3 patients refused to give informed consent). Sinus
Abbreviations and Acronyms
ECG 5 electrocardiographic
HF 5 high frequency area of power
spectral analysis
LF 5 low frequency area of power
spectral analysis
LV 5 left ventricular
MSSD 5 mean squared successive difference
pNN50 5 percent of normal to normal
intervals differing from preceding
one by .50 ms
VT 5 ventricular tachycardia
Table 1. Clinical Characteristics of the Study Patients
Group 1
(n 5 11)
Group 2
(n 5 13)
p
Value
Age (yr) 66 6 7 66 6 8 0.86
Anterior MI 2 of 11 4 of 13 0.83
Years after MI 12 6 9 13 6 9 0.85
LV aneurysm 8 of 11 8 of 13 0.88
LV EF (%) 40 6 12 34 6 11 0.25
Duration of clinical VT (h) 3.6 6 2.6 2.3 6 2.1 0.08
Cycle of clinical VT (ms) 330 6 53 311 6 38 0.31
Cycle of induced VT (ms) 294 6 40 317 6 55 0.33
Data are expressed as mean value 6 SD or number of patients. Group 1 5
patients with well tolerated ventricular tachycardia (VT); group 25 patients with
poorly tolerated VT; EF 5 ejection fraction; LV 5 left ventricular; MI 5
myocardial infarction.
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node function was normal in every patient. VT was induced in
every patient except one patient in group 1. The cycle length of
the induced VT was similar in the two groups. Stable 2:1
ventriculoatrial retrograde conduction was observed in one
group 1 patient and two group 2 patients. In all other patients
atrioventricular dissociation was found. A discordance be-
tween the tolerability of the clinical and the induced VT was
observed in 5 of 20 patients. Two group 1 patients had syncope
after induction of a VT that had a faster rate than that of the
clinical VT; conversely, in three group 2 patients the induced
VT was well tolerated.
Drug treatment at the time of the study was similar. Six
patients in group 1 and seven in group 2 were not treated with
any cardioactive drug; four and three patients, respectively,
were treated with angiotensin-converting enzyme inhibitors;
one and three patients, respectively, were treated with amio-
darone. No patient was taking a beta-adrenergic blocking drug
or digoxin.
Autonomic variables. Analysis of the rest 10-min RR re-
cording (Table 2) disclosed no differences between groups in
the mean RR interval or its SD, MSSD or pNN50. Power
spectral analysis also showed no significant difference between
the two groups in the power contained in the LF and HF areas,
expressed either as absolute or as normalized (11,12) values, or
in the LF/HF ratio, which has been proposed as an index of
sympathovagal balance (11,12). Figure 1 shows the almost
complete overlap of values between the two groups for age, LV
ejection fraction, cycle length of the tachycardia and SD of the
RR interval.
At variance with the results of heart rate variability, barore-
flex sensitivity showed a marked difference between the two
groups, (7.1 6 3.7 ms/mm Hg in group 1 vs. 3.4 6 1.1 ms/mm
Hg in group 2, p 5 0.003, Fig. 2). The statistical significance
Figure 1. Plot of individual values for age, cycle length of ventricular
tachycardia (VT cycle), left ventricular ejection fraction (LVEF) and
standard deviation of the RR interval (SD) of patients in group 1 (well
tolerated VT) and group 2 (poorly tolerated VT). The data show an
almost complete overlap of values between the two groups.
Table 2. Heart Rate Variability in the Study Patients
Group 1
(n 5 11)
Group 2
(n 5 13)
p
Value
Mean RR interval (ms) 820 6 63 880 6 174 0.27
Mean SD of RR interval (ms) 266 10 26 6 15 0.96
Coefficient of variance (%) 3.2 6 1.3 3.0 6 1.5 0.68
MSSD (ms) 14 6 6 15 6 9 0.76
pNN50 (%) 0.9 6 1.6 (0.2) 2.3 6 3.8 (0.4) 0.35
LF (ms2) 558 6 565 (232) 511 6 718 (262) 0.87
LF (normalized units) 77 6 12 69 6 20 0.25
HF (ms2) 128 6 119 (92) 198 6 389 (87) 0.90
HF (normalized units) 23 6 12 31 6 20 0.25
LF/HF 5.8 6 5.8 (3.5) 3.9 6 3.5 (2.6) 0.38
The data are the average of two 10-min recordings in rest conditions and are
expressed as mean value 6 SD (median). HF and LF 5 high and low frequency
areas of power spectral analysis, respectively; MSSD 5 mean squared successive
difference; pNN50 5 percent of normal to normal intervals differing from the
preceding one by .50 ms; SD 5 standard deviation. Groups 1 and 2 are defined
in Table 1.
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remained unchanged after exclusion from group 1 of the
patient with the highest baroreflex sensitivity.
A multiple logistic regression analysis using age, LV ejec-
tion fraction, cycle length of the tachycardia, SD of the RR
interval and baroreflex sensitivity as variables showed that only
baroreflex sensitivity (chi-square improvement 14.2, p 5
0.0003)—but not age, LV ejection fraction, VT cycle length or
SD of the RR interval (all p . 0.25)—correlated with the
tolerability of VT.
Follow-up. Twenty-three patients were prospectively fol-
lowed up for an average of 24 months (median 21, p 5 NS
between the two groups) after the index arrhythmia; one
patient was lost to follow-up. Six patients had a cardiac death
(documented ventricular fibrillation or witnessed sudden death
in three), and four others had a nonfatal recurrence of VT (in
two the arrhythmia was well tolerated for several hours, in two
it was associated with hemodynamic deterioration).
Patients with either cardiac death or hemodynamically
unstable VT during the follow-up period (n5 8) were assigned
to follow-up group B, whereas patients with neither of these
events were assigned to follow-up group A (n 5 15). Patients
in group B had a lower LV ejection fraction (27 6 5% vs. 42 6
11%, p5 0.001) and a lower baroreflex sensitivity (2.96 1.1 vs.
5.9 6 3.3 ms/mm Hg, p 5 0.003) than did patients in group A.
No difference was found in any other clinical or autonomic
variable, including age (65 6 10 vs. 67 6 6 years), SD of the
RR interval (21 6 7 vs. 27 6 14 ms), LF (69 6 17 vs. 73 6 17
normalized units) and HF (31 6 17 vs. 27 6 17 normalized
units) spectral powers and VT cycle (327 6 28 vs. 313 6
53 ms). The statistical significance of baroreflex sensitivity
remained unchanged after exclusion from group A of the
patient with the highest value. The two patients with a recur-
rence of stable VT had a baroreflex sensitivity of 6.0 and 6.9
ms/mm Hg, respectively.
Multiple logistic regression analysis indicated that LV ejec-
tion fraction and baroreflex sensitivity—but not age, tachycar-
dia cycle length, SD of the RR interval or hemodynamic
tolerability of the VT—predicted cardiac death or unstable VT
(p for model improvement 5 0.0001 and 0.0003 for LV
ejection fraction and baroreflex sensitivity, respectively). Fig-
ure 3 shows the individual values of patients without (group A)
or with (group B) cardiac death or unstable VT in the
follow-up period.
Discussion
Several clinical and autonomic variables were evaluated in
patients with a healed myocardial infarction presenting with
sustained monomorphic VT. When compared with patients
without hemodynamic problems, those with poorly tolerated
VT had similar clinical characteristics, including age, LV
function and VT rate, as well as similar heart rate variability,
but they had a significantly lower baroreflex sensitivity.
These findings offer insights on the two-way relation be-
tween sustained VT and autonomic mechanisms and have
practical implications for the risk stratification and therapeutic
strategy for patients with VT.
Determinants of hemodynamic tolerability of VT. Several
factors play a role in the hemodynamic response to VT (2). A
fast heart rate decreases cardiac output, mainly because of the
shortening of diastole, and this effect is markedly exaggerated
in patients with impaired LV function. Cardiac output is also
correlated with ejection fraction during VT, whereas the
correlation with the ejection fraction measured during sinus
rhythm is uncertain.
Hamer et al. (1) evaluated the factors that predict syncope
during VT induced in the electrophysiologic laboratory (1).
They found that older age, low ejection fraction and reduced
cardiac output during sinus rhythm did not correlate with the
induction of syncope. A relation was found with the rate of the
VT; that is, no syncope occurred at rates ,200 beats/min, and
no patient maintained consciousness in the electrophysiologic
laboratory at rates .230 beats/min.
Whereas Hamer et al. studied electrically induced VT, we
examined the tolerability of the clinical VT. We did not
observe a significant relation between VT cycle and tolerability
and found, indeed, a wide area of overlap between our two
patient groups (i.e., VT rates were as high as 240 beats/min in
group 1 and as low as 167 beats/min in group 2 [poorly
tolerated VT, see Fig. 1]). Like Hamer et al., we did not
observe significant differences between the two groups in age
or LV ejection fraction.
Other factors considered to play a role in hemodynamic
status during VT include the potential occurrence of myocar-
dial ischemia at high heart rates and the neurohumoral re-
sponse to VT (2,13). No patient enrolled in this study had an
indication for myocardial revascularization on the basis of
coronary arteriography and tests for the induction of myocar-
dial ischemia. Thus, although myocardial ischemia may well
have developed during the VT, its development is unlikely to
represent a major cause for the differences in VT tolerability
observed in our two groups.
No difference was found in any measure of heart rate
variability, including LF and HF components of spectral power
Figure 2. Plot of individual values for baroreflex sensitivity (BRS) of
patients in groups 1 and 2. The mean value 6 SD for both groups is
also shown. Groups are defined in Figure 1.
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and their ratio. The HF component mainly derives from vagal
modulation, whereas the LF component is likely to derive from
both sympathetic and vagal modulations (12). The sympathetic
contribution is considered to be predominant by several inves-
tigators, thus suggesting that LF expressed in normalized units
may closely reflect sympathetic modulation (12). Similarly, the
LF/HF ratio is considered to mirror sympathovagal balance
(11,12). The absence of any difference in these variables
suggests that tonic autonomic modulation in the supine posi-
tion does not differ in the two groups of patients and that,
accordingly, indexes of autonomic modulation of heart rate,
assessed in baseline conditions, do not provide information on
the tolerability of an episode of VT. In contrast, the presence
of maintained baroreceptor reflexes did identify patients with a
decreased incidence of hemodynamic symptoms during the
arrhythmia.
Autonomic reflexes during VT. Baroreceptor responsive-
ness can be assessed by several techniques. It is possible to
derive an index of baroreceptor responsiveness in a closed loop
system, in the absence of any disturbance from the outside.
Methods that utilize the combined analyses of heart period and
blood pressure variabilities to assess the overall gain of barore-
flex mechanisms include analysis of the spontaneous ramp of
blood pressure and heart period (14) and the computation of
the a index derived from spectral analysis of both heart period
and systolic blood pressure signals (15). However, because the
onset of sustained VT causes a major disturbance to the
system, we preferred a method that would be more suited to
assess ability to react to a hemodynamic disturbance.
Baroreceptor reflexes may be provoked by either loading or
unloading the receptors. The use of a neck chamber to
deactivate carotid baroreceptors and to analyze the reflex
control of both heart rate and peripheral resistance may have
been an alternative means to gain insights into the potential
response to VT. We favored the phenylephrine method to
assess baroreflex sensitivity for several main reasons. 1) It is
much simpler than the neck chamber method (16). 2) It is
gaining increasing popularity, partly because of its use in a
large international study in patients after myocardial infarction
(16,17), and it is widely available. 3) Prognostic correlates are
available for baroreflex sensitivity assessed with the phenyleph-
rine method (4,6,17) but not with any other technique. 4)
Studies in patients after myocardial infarction (18) or with New
York Heart Association class I and II heart failure (19)
(patients similar to those in the present study) indicate that in
these patients, baroreceptor responsiveness to both loading
and unloading is depressed by a similar extent. 5) The magni-
tude of heart rate reduction during phenylephrine was found
Figure 3. Plot of individual values for cycle length of ventricular
tachycardia (VT), left ventricular ejection fraction (LVEF), baroreflex
sensitivity (BRS), cycle length of ventricular tachycardia (VT) and
standard deviation of the RR interval (SD) of patients in groups A and
B. Group B comprised patients with either cardiac death or unstable
VT during follow-up; group A comprised patients with neither of these
two end points. Mean 6 SD values are also shown for significantly
different variables.
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to be correlated with the increase in muscle sympathetic nerve
activity during baroreceptor unloading (19).
It must be appreciated that VT generates a complex variety
of reflex responses. In addition to those mediated by barore-
ceptors, these responses may include reflexes originating from
the heart itself, specifically from mechanoreceptors located in
the abnormally contracting areas of the ventricles and in the
distended atrium (20–22), and reflexes caused by ischemia,
such as general sympathoexcitation after cerebral ischemia
(23) or the renorenal sympathetic reflex (24). The effects of VT
are complex even on baroreceptors, because during the ar-
rhythmia arterial baroreceptors are unloaded, whereas cardio-
pulmonary baroreceptors are stimulated (25). Thus, simple
baroreceptor unloading creates a condition that is still quite
different from that occurring during VT.
The findings of the present study suggest that assessment of
baroreceptor reflexes with the phenylephrine method may
identify patients with a better ability to compensate for the
hemodynamic disturbances caused by VT. This hypothesis is in
good agreement with the suggestion by Steinbach et al. (2) that
the flexibility of the reaction to VT is decisive for its tolerabil-
ity, as patients with a higher baroreflex sensitivity have more
flexible cardiovascular reflexes.
The unfavorable hemodynamic profile of patients with
poorly tolerated VT may depend on inadequate sympathetic
drive during the arrhythmia. This hypothesis is supported by
both human and animal studies. Smith et al. (26) suggested
that the preservation of arterial pressure during induced VT
was directly related to the magnitude of sympathoexcitation in
response to the arrhythmia. Their observations, combined with
the reported correlation present between the magnitude of
heart rate reduction during phenylephrine administration and
the increase in muscle sympathetic nerve activity during
baroreceptor unloading (19), strongly suggest that patients
with a depressed response to phenylephrine do not tolerate the
VT because of inadequate arterial baroreflex–mediated sym-
pathoexcitation. Indeed, a recent animal study (27) suggests
that arterial baroreflex–mediated sympathoexcitation plays
the key role in determining the hemodynamic outcome
during VT.
Prognostic value of baroreflex sensitivity in patients with
myocardial infarction. Both heart rate variability and barore-
flex sensitivity correlate with mortality after myocardial infarc-
tion (3–7). Very recent data from an international multicenter
prospective trial obtained in 1,280 postmyocardial infarction
patients (17) definitively demonstrate that a depressed barore-
flex sensitivity is a strong predictor of cardiac mortality and
they indicate that its predictive value is independent of LV
ejection fraction.
A high baroreflex sensitivity may correlate with a decreased
likelihood of sudden death by more than one mechanism.
Experimental evidence (8,28) indicates that animals with
higher baroreflex sensitivity are capable of activating more
powerful vagal reflexes in response to acute myocardial isch-
emia, thus counteracting the detrimental effects of sympathetic
hyperactivity and decreasing the likelihood of ventricular fi-
brillation. Clinical studies (10,29) suggest that a low baroreflex
sensitivity may also correlate with the likelihood of sustained
VT in the absence of acute ischemia. The present study raises
a third possibility: A low baroreflex sensitivity may correlate
with arrhythmic death due to hemodynamic deterioration
associated with a sustained VT.
Prognostic value of baroreflex sensitivity in patients with
VT. Patients who had either a cardiac death or a recurrence of
an unstable VT during follow-up were characterized by a
marked depression of baroreceptor reflexes, compared with
patients who did not have these events. In contrast, the two
groups did not differ in indexes of heart rate variability,
including time domain measures and power spectral measures
(either in absolute or in normalized units). These findings are
not completely unexpected because both experimental (30,31)
and clinical (6,10,29) studies have suggested that measures of
autonomic reflex modulation may correlate better than mea-
sures of autonomic tonic modulation with the likelihood of
malignant arrhythmias.
Because the predictive value of baroreflex sensitivity ap-
pears to be independent of LV function, the analysis of
autonomic reflexes may play a role in the risk stratification of
patients with sustained VT.
Potential implications. The present findings may have sev-
eral implications. Knowledge of the baroreceptive function of
a patient may help in tailoring the therapeutic approach. For
example, a more aggressive treatment might be justified for the
patient with inducible VT and a very depressed baroreflex
function even in the absence of clinical episodes of sustained
VT. Conversely, a patient with clinical episodes of sustained
monomorphic VT but a well preserved baroreflex function
could be evaluated with antiarrhythmic drugs before the
option of cardioverter-defibrillator implantation is consid-
ered. This approach would be justified by the good tolera-
bility of the VT, which would allow sufficient time for the
patient to seek and receive appropriate medical care.
Also, in selected patients with severely depressed baroreflex
function (for example, a few patients early after myocardial
infarction or many with advanced heart failure), an interven-
tion that increases baroreflex sensitivity, such as regular exer-
cise training (32), may decrease the likelihood of syncope and
sudden death should sustained VT develop. An effort to
increase baroreflex sensitivity could also be part of the thera-
peutic strategy in patients in whom markedly depressed
baroreceptor reflexes appear to play a key role in the occur-
rence of hemodynamic symptoms during VT.
Limitations of the study. This study has the following
potential limitations:
1) It involves a relatively small number of patients and the
results therefore need to be confirmed in a larger group.
2) Heart rate variability was assessed from a short-term
recording in controlled conditions. Little experience exists
linking short-term measures of heart rate variability with
mortality. Although a few studies (33,34) have shown a corre-
lation between short-term measures of heart rate variability
and prognosis after myocardial infarction, this method appears
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less efficient for risk stratification than the analysis of 24-h
recordings. Also, it is possible that the analysis of heart rate
variability after an excitatory stimulus, such as a head-up tilt
test, might have disclosed relevant information that cannot be
provided by a recording obtained with the patient supine.
Therefore, the lack of difference in heart rate variability
between our two groups of patients is not conclusive evidence
that this marker has no prognostic value in patients with
sustained VT. However, the results do suggest that the stan-
dard supine measurement of heart rate variability is less
powerful than baroreflex sensitivity in risk stratification of
patients with sustained VT.
3) Autonomic assessment was performed after occurrence
of the arrhythmia, and the hemodynamic end point, although
in most cases it was a true syncopal episode with loss of
consciousness, is not a “hard” end point (such as death) for
recurrence of VT. However, because the assessment was
performed shortly after (3 to 7 days) the index arrhythmia, it
represents a sort of autonomic “snapshot” useful for under-
standing the pathophysiologic mechanism. Also, the pro-
spective part of the study suggests that baroreflex sensitivity
may identify patients with subsequent cardiac death or
unstable VT.
4) Finally, we clearly did not study patients with the most
poorly tolerated VT, that is, those who die because of a rapid
deterioration of VT into VF. Patients referred for defibrillator
implantation may bear the closest resemblance to patients in
this category. The finding (29) that their baroreflex sensitivity
appears to be even more depressed than that observed in our
group 2 patients (poorly tolerated VT) is in agreement with the
hypothesis of our study.
Conclusions. Low baroreflex sensitivity values identify pa-
tients with a poor ability to tolerate VT hemodynamically and
a worse prognosis than that of patients with higher values. This
finding suggests that an impaired cardiovascular reflex re-
sponse may play a key role in the hemodynamic deterioration
of sustained VT. It also suggests that a better hemodynamic
response during VT may be an additional mechanism under-
lying the relation between preserved baroreflex sensitivity and
a reduced incidence of cardiac death after myocardial infarc-
tion. Finally, the evaluation of baroreflex sensitivity in patients
at high risk for sustained VT may become useful both in risk
stratification and in the individualization of treatment.
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